Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

Robert P. Giugliano, Terje R. Pedersen, Jeong-Gun Park, +16

The Lancet

Cardiovascular DiseasePcsk9 Inhibitor EvolocumabPharmacologyClinical TrialsHyperlipidemia +7

Epidemiology of Shock in Contemporary Cardiac Intensive Care Units

David D. Berg, Erin A. Bohula, Sean van Diepen, +31

Circulation Cardiovascular Quality and Outcomes

Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

Nimalie D. Stone, Shelia B. Dunaway, Charles Flexner, +13

Antimicrobial Agents and Chemotherapy

Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188

Mary Vogler, Kristine B. Patterson, Lori Kamemoto, +5

JAIDS Journal of Acquired Immune Deficiency Syndromes

Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry

David D. Berg, Christopher F. Barnett, Benjamin B. Kenigsberg, +38

Circulation Heart Failure

Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis

Elin M. Svensson, Francesca Aweeka, Jeong-Gun Park, +3

Antimicrobial Agents and Chemotherapy

Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers

Kelly E. Dooley, Jeong-Gun Park, Susan Swindells, +10

JAIDS Journal of Acquired Immune Deficiency Syndromes

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093

D. Heather Watts, Jeong-Gun Park, Susan E. Cohn, +6

Contraception

Depot Medroxyprogesterone AcetateAntiretroviral TherapyHormonal ContraceptiveTreatment And PreventionPharmacology +6

Sex Differences in Lopinavir and Ritonavir Pharmacokinetics Among HIV-Infected Women and Men

Obi Umeh, Judith S. Currier, Jeong-Gun Park, +3

The Journal of Clinical Pharmacology

PharmacotherapyAntiviral DrugHiv-infected WomenSocial SciencesLpv Pharmacokinetics +17

Using Selection Criteria From the DanGer Shock Trial in a Contemporary Cohort With Cardiogenic Shock

Connor O’Brien, Samuel B. Brusca, Christopher F. Barnett, +5

Journal of the American College of Cardiology

Cardiogenic ShockCardiovascular EpidemiologyCardiovascular DiseaseAdverse EventMedicine +8